PubMed:7565683 / 615-866 JSONTXT

{"project":"jnlpba-st-training","denotations":[{"id":"T12","span":{"begin":48,"end":58},"obj":"protein"},{"id":"T13","span":{"begin":221,"end":250},"obj":"protein"}],"text":"In addition, pretreatment of the cells with the proteasome inhibitor N-Ac-Leu-Leu-norleucinal inhibits this ligand-induced degradation and, in agreement with previous studies, stabilizes a hyperphosphorylated form of the human I kappa B alpha protein."}

{"project":"pubmed-sentences-benchmark","denotations":[{"id":"S4","span":{"begin":0,"end":251},"obj":"Sentence"}],"text":"In addition, pretreatment of the cells with the proteasome inhibitor N-Ac-Leu-Leu-norleucinal inhibits this ligand-induced degradation and, in agreement with previous studies, stabilizes a hyperphosphorylated form of the human I kappa B alpha protein."}

{"project":"genia-medco-coref","denotations":[{"id":"C10","span":{"begin":29,"end":38},"obj":"NP"},{"id":"C11","span":{"begin":103,"end":134},"obj":"NP"},{"id":"C12","span":{"begin":217,"end":250},"obj":"NP"}],"text":"In addition, pretreatment of the cells with the proteasome inhibitor N-Ac-Leu-Leu-norleucinal inhibits this ligand-induced degradation and, in agreement with previous studies, stabilizes a hyperphosphorylated form of the human I kappa B alpha protein."}

{"project":"GENIAcorpus","denotations":[{"id":"T18","span":{"begin":48,"end":58},"obj":"protein_complex"},{"id":"T19","span":{"begin":69,"end":93},"obj":"other_organic_compound"},{"id":"T20","span":{"begin":221,"end":226},"obj":"protein_molecule"},{"id":"T21","span":{"begin":227,"end":242},"obj":"protein_molecule"}],"text":"In addition, pretreatment of the cells with the proteasome inhibitor N-Ac-Leu-Leu-norleucinal inhibits this ligand-induced degradation and, in agreement with previous studies, stabilizes a hyperphosphorylated form of the human I kappa B alpha protein."}